Drug Discovery & Pharmaceuticals

RSS

Researchers develop AI-based strategy for discovering high-affinity antibody drugs

Scientists at University of California San Diego School of Medicine have developed an artificial intelligence (AI)-based strategy for discovering high-affinity antibody drugs.

30 Jan 2023

New candidate molecule could become an effective non-hormonal male contraceptive

Despite birth control existing for decades, almost none of the options specifically target sperm cells. Researchers are now developing approaches that target testosterone or otherwise interrupt the sperm's ability to fertilize an egg, yet these may not work for everyone.

30 Jan 2023

Machine learning identifies drugs that could be repurposed to help people quit smoking cigarettes

Medications like dextromethorphan, used to treat coughs caused by cold and flu, could potentially be repurposed to help people quit smoking cigarettes, according to a study by Penn State College of Medicine and University of Minnesota researchers.

30 Jan 2023

$1 million grant will help University of Utah chemists to speed up the drug development process

Michael Grünwald, Ryan Looper and Rodrigo Noriega, of the University of Utah Department of Chemistry, received a $1 million grant from the W.M. Keck Foundation funding studies of currently unpredictable aspects of the process of crystallization.

30 Jan 2023

Novel class of sulfonamides to block malaria transmission

Malaria is a devastating disease, with 247 million cases and 619,000 deaths reported in 2021 alone. Malaria causes fever and a flu-like illness that occurs when people are infected with the parasite Plasmodium falciparum, which is spread by mosquitoes.

30 Jan 2023

A high-throughput screening assay for small molecule inhibitors of the antigen aminopeptidase ERAP1

The January 2023 issue of SLAS Discovery contains a collection of four full-length articles and one technical brief covering cancer research, high-throughput screening (HTS) assay development and other drug discovery exploration.

27 Jan 2023

New spray can have a dual impact in the fight against antibiotic resistance

The World Health Organization ranks antibiotic resistance as one of the top ten threats to global health. There is therefore a great need for new solutions to tackle resistant bacteria and reduce the use of antibiotics.

26 Jan 2023

Aston University scientists team up with Isterian Biotech to develop novel drugs to treat fibrotic diseases

Aston University scientists are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as lung disease.

23 Jan 2023

Hypertension drug can extend lifespan and slow aging

Researchers have found that the drug rilmenidine can extend lifespan and slow aging.

23 Jan 2023

Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today announced it is supporting a Master’s student at the University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neurodegenerative, renal, and cardiovascular diseases.

From Ubiquigent Limited 23 Jan 2023

BioEcho launches EchoLUTION™ Cell Culture RNA Kit for an efficient and simplified cell RNA extraction

BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, announces the EchoLUTION Cell Culture RNA Kit launch, for an innovative total RNA extraction of any kind of cultured cells.

From BioEcho Life Sciences GmbH 23 Jan 2023

Researchers create the first 'living medicine' to treat drug-resistant lung infections

Researchers have designed the first 'living medicine' to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antibiotics and is a common source of infections in hospitals.

19 Jan 2023

Drug Discovery & Pharmaceuticals

Researchers develop AI-based strategy for discovering high-affinity antibody drugs

New candidate molecule could become an effective non-hormonal male contraceptive

Machine learning identifies drugs that could be repurposed to help people quit smoking cigarettes

$1 million grant will help University of Utah chemists to speed up the drug development process

Novel class of sulfonamides to block malaria transmission

A high-throughput screening assay for small molecule inhibitors of the antigen aminopeptidase ERAP1

New spray can have a dual impact in the fight against antibiotic resistance

Aston University scientists team up with Isterian Biotech to develop novel drugs to treat fibrotic diseases

Hypertension drug can extend lifespan and slow aging

Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field

BioEcho launches EchoLUTION™ Cell Culture RNA Kit for an efficient and simplified cell RNA extraction

Researchers create the first 'living medicine' to treat drug-resistant lung infections

Experimental regenerative medicine shows potential to restore bone in an animal

2023 EVIDENT Organoid Conference to share the latest organoid innovations

Novel peptide suppresses the damaging lung inflammation seen in ARDS

Future COVID-19 control will require vaccines that induce better mucosal immunity

Using the power of light to transform analytical workflows in the life sciences

Anticancer drugs offer new hope for treatment of sepsis

Developing new tools to accelerate spatial genomics and drug discovery

Using machine learning models to guide the design of long-acting injectable drug formulations

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest Life Science News